A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination.

Saved in:
Bibliographic Details
Title: A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination.
Authors: Lemke MM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., McLean MR; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Lee CY; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Lopez E; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Bozich ER; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Rerks-Ngarm S; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand., Pitisuttithum P; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Nitayaphan S; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand., Kratochvil S; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Wines BD; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia., Hogarth PM; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia., Kent SJ; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre, Alfred Hospital, Monash University Central Clinical School, Carlton, VIC, Australia., Chung AW; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Arnold KB; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Source: Cell reports. Medicine [Cell Rep Med] 2021 Sep 01; Vol. 2 (9), pp. 100386. Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med
Database: MEDLINE Ultimate
Description
ISSN:2666-3791
DOI:10.1016/j.xcrm.2021.100386